Morphologic features of prostatic adenocarcinoma in the radical prostatectomy (RP) specimen are powerful prognostic indicators for prognosis for disease-free survival. This review discusses the methods of sampling of the RP specimen to optimize the detection of these morphologic features, balanced against the added expense of submitting the entire gland for sectioning. Gleason grade, one of the most powerful prognostic factors, is discussed briefly, including the percent pattern 4/5 cancer compared to the standard Gleason grading. Pathologic stage, as defined by the TNM system, is discussed in detail, both in terms of precise histological definition of each category, as well as the associated prognostic implications. Surgical margin status is also important prognostically across all pathologic stages categories. Perineural invasion, which has been used diagnostically in prostate cancer for several decades, has emerged as a very important prognostic indicator as well, as determined by the quantitative aspects of tumor in the perineural space. The effect of tumor volume on prognosis is discussed, as well as the newer concepts of the prognostic significance of zone of origin of the tumor and the presence or absence of intraductal carcinoma. Keywords: prostate carcinoma; pathologic stage; radical prostatectomy Radical prostatectomy (RP) for carcinoma of the prostate was performed and reported 100 years ago at the Johns Hopkins hospital by Dr Hugh Hampton Young who utilized a transperineal approach. He reported this and several other cases in the Bulletin of the Johns Hopkins Hospital. 1 Major impediments to utilizing RP in the years that followed related primarily to the almost universal presence of impotence and less commonly incontinence following the surgery. Also a large proportion of cases were first diagnosed with stage IV disease before widespread awareness of the disease and the advent of screening with serum prostate-specific antigen (PSA) in the late 1980s. In addition, initially there were high expectations for hormonal therapy in the 1940s and radiation therapy in the years that followed. However, it became clear very early that hormonal therapy could delay but not halt the progression of disease. Also radiotherapy was fraught with a high frequency of post-therapy positive biopsies and subsequent late recurrence; and for the latter, at times a much less differentiated tumor.The resurgence of RP for prostate cancer was brought about by another surgeon at Johns Hopkins, Patrick Walsh, MD, who along with Donker, reported on the anatomical distribution of nerves to the penile corpora in the male fetus. They subsequently designed an operation (now called 'anatomical RP') that would spare these nerves, which were located in the neurovascular bundle next to the postero-lateral aspect of the prostate. 2 In this paper he also reported a small series of patients he had treated by this new method of RP and reported postoperative potency rates. Although the postoperative potency rate were far from perfect, these res...